Targeting RNA in mammalian systems with small molecules

• Published in: Wiley interdisciplinary reviews. RNA 2018-07, Vol.9 (4), p.e1477-n/a
• Main Authors: Donlic, Anita, Hargrove, Amanda E.
• Format: Article
• Language: English
• Subjects: Animals; biological systems; chemical probes; Disease; Epigenetics; expanded repeats; Genomes; G‐quadruplex; Humans; ligand; long non‐coding RNA; mammalian; Mammals; microRNA; miRNA; Neoplasms - drug therapy; Neoplasms - genetics; Neoplasms - metabolism; Nervous System Diseases - genetics; Nervous System Diseases - metabolism; Neurological diseases; Phenotype; Phenotypes; Protein biosynthesis; RNA; RNA - chemistry; RNA - genetics; RNA - metabolism; RNA in disease; RNA interactions; RNA probes; RNA Probes - chemistry; RNA Probes - pharmacology; RNA Splice Sites - drug effects; RNA Splice Sites - genetics; RNA structure; RNA therapeutic target; small molecule; Small Molecule Libraries - chemistry; Small Molecule Libraries - pharmacology; splice sites; Splicing; Therapeutic applications; Transcription
• ISSN: 1757-7004; 1757-7012; 1757-7012
• DOI: 10.1002/wrna.1477

The recognition of RNA functions beyond canonical protein synthesis has challenged the central dogma of molecular biology. Indeed, RNA is now known to directly regulate many important cellular processes, including transcription, splicing, translation, and epigenetic modifications. The misregulation of these processes in disease has led to an appreciation of RNA as a therapeutic target. This potential was first recognized in bacteria and viruses, but discoveries of new RNA classes following the sequencing of the human genome have invigorated exploration of its disease‐related functions in mammals. As stable structure formation is evolving as a hallmark of mammalian RNAs, the prospect of utilizing small molecules to specifically probe the function of RNA structural domains and their interactions is gaining increased recognition. To date, researchers have discovered bioactive small molecules that modulate phenotypes by binding to expanded repeats, microRNAs, G‐quadruplex structures, and RNA splice sites in neurological disorders, cancers, and other diseases. The lessons learned from achieving these successes both call for additional studies and encourage exploration of the plethora of mammalian RNAs whose precise mechanisms of action remain to be elucidated. Efforts toward understanding fundamental principles of small molecule–RNA recognition combined with advances in methodology development should pave the way toward targeting emerging RNA classes such as long noncoding RNAs. Together, these endeavors can unlock the full potential of small molecule‐based probing of RNA‐regulated processes and enable us to discover new biology and underexplored avenues for therapeutic intervention in human disease. This article is categorized under: RNA Methods > RNA Analyses In Vitro and In Silico RNA Interactions with Proteins and Other Molecules > Small Molecule–RNA Interactions RNA in Disease and Development > RNA in Disease Small molecules have been successfully used to study several mammalian RNA elements in disease. These advances encourage exploration of newly discovered RNA interactions with therapeutic potential.